Compounds > carbostyril
Page last updated: 2024-08-17

carbostyril and Squamous Cell Carcinoma of Head and Neck

carbostyril has been researched along with Squamous Cell Carcinoma of Head and Neck in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's6 (85.71)2.80

Authors

AuthorsStudies
Chen, Z; Chen, ZG; El-Deiry, M; Griffith, CC; Nannapaneni, S; Patel, M; Saba, NF; Shin, DM; Shu, L; Sun, Y; Wang, D; Wang, X1
Aizenbud, I; Amit, I; Barel, O; Capucha, T; Czerninski, R; David, E; Eli-Berchoer, L; Hovav, AH; Koren, N; Matanes, D; Saba, Y; Stoitzner, P; Wilensky, A; Yona, S; Zubeidat, K1
Callejas-Valera, JL; Gillenwater, AM; Richards-Kortum, RR; Schwarz, RA; Tan, MT; Vigneswaran, N; Wu, JG1
Burrows, F; Calleja-Valera, JL; Chillà, A; Ferrara, N; Gilardi, M; Goto, Y; Gualberto, A; Gutkind, JS; Janes, MR; Mikulski, Z; Molinolo, AA; Proietto, M; Vanoni, M; Wang, Z1
Carneiro, ACDM; Crema, VO; De Vito, FB; Moraes-Souza, H1
Hartgerink, JD; Leach, DG; Myers, JN; Osman, AA; Rangel, R; Ren, X; Shi, Y; Sikora, AG; Wang, B; Xie, TX; Young, S1
Brands, RC; De Donno, F; Hartmann, S; Knierim, LM; Kübler, AC; Müller-Richter, UDA; Seher, A; Steinacker, V1

Other Studies

7 other study(ies) available for carbostyril and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
    Oral oncology, 2021, Volume: 122

    Topics: Animals; Cell Line, Tumor; Cetuximab; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Mice; Quinolones; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2021
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen.
    Proceedings of the National Academy of Sciences of the United States of America, 2022, 01-18, Volume: 119, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Antineoplastic Agents; Carcinogens; Cell Line, Tumor; Dendritic Cells; Epithelial Cells; Epithelium; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histones; Humans; Immunity; Langerhans Cells; Phagocytes; Quinolones; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes, Regulatory; Tongue; Transcriptome

2022
A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.
    International journal of experimental pathology, 2020, Volume: 101, Issue:1-2

    Topics: 4-Nitroquinoline-1-oxide; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Disease Progression; Lymphocytes; Mice, Inbred CBA; Mice, Transgenic; Mutation; Oncogene Proteins, Viral; Quinolones; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms

2020
Tipifarnib as a Precision Therapy for
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:9

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Head and Neck Neoplasms; Humans; Male; MAP Kinase Signaling System; Mice; Mutation; Precision Medicine; Prenylation; Proto-Oncogene Proteins p21(ras); Quinolones; Sequence Analysis, RNA; Squamous Cell Carcinoma of Head and Neck

2020
RhoA/ROCKs signaling is increased by treatment with TKI-258 and leads to increased apoptosis in SCC-4 oral squamous cell carcinoma cell line.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2021, Volume: 50, Issue:4

    Topics: Apoptosis; Benzimidazoles; Carcinoma, Squamous Cell; Cell Line; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Quinolones; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

2021
Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
    Cancer prevention research (Philadelphia, Pa.), 2021, Volume: 14, Issue:8

    Topics: 4-Nitroquinoline-1-oxide; Animals; Antibodies, Monoclonal; Carcinogenesis; Disease Models, Animal; Drug Delivery Systems; Female; Genes, p53; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Injections, Intralesional; Male; Mice; Mice, Transgenic; Mouth Neoplasms; Precancerous Conditions; Programmed Cell Death 1 Receptor; Quinolones; Squamous Cell Carcinoma of Head and Neck

2021
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro.
    Oncology reports, 2017, Volume: 38, Issue:3

    Topics: Benzimidazoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Indazoles; Indoles; Male; Protein Kinase Inhibitors; Pyrimidines; Quinolones; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Sulfonamides

2017